Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK

References

• Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol. 2000;32:757–64.
   PubMed Web of Science ®Google Scholar
• Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191–8.
   PubMed Web of Science ®Google Scholar
• Jonassen AK, Mjos OD, Sack MN. p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem Biophys Res Commun. 2004;315:160–5.
   PubMed Web of Science ®Google Scholar
• Xing W, Yan W, Fu F, Jin Y, Ji L, Liu W, et al. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function. Apoptosis. 2009;14:1050–60.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med. 2005;15:69–75.
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88.
   PubMed Web of Science ®Google Scholar
• Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105:1497–502.
   PubMed Web of Science ®Google Scholar
• Vigneron F, Dos Santos P, Lemoine S, Bonnet M, Tariosse L, Couffinhal T, et al. GSK-3beta at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Cardiovasc Res. 2011;90:49–56.
   PubMed Web of Science ®Google Scholar
• Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol. 2006;38:414–9.
   PubMed Web of Science ®Google Scholar
• Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res. 2007;75:168–77.
   PubMed Web of Science ®Google Scholar
• Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol. 2011;106:135–45.
   PubMed Web of Science ®Google Scholar
• Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, et al. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K + channel and protein kinase C activation. Basic Res Cardiol. 2006;101:180–9.
   PubMed Web of Science ®Google Scholar
• Jin C, Wu J, Watanabe M, Okada T, Iesaki T. Mitochondrial K+ channels are involved in ischemic postconditioning in rat hearts. JPS. 2012;62:325–32.
   Google Scholar
• Hausenloy DJ, Wynne AM, Yellon DM. Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol. 2007;102:445–52.
   PubMed Web of Science ®Google Scholar
• Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, et al. A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart. Biochem Biophys Res Commun. 2005;338:1460–6.
   PubMed Web of Science ®Google Scholar
• Perrelli MG, Tullio F, Angotti C, Cerra MC, Angelone T, Tota B, et al. Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling. Pflugers Archiv. 2013;465:1031–40.
   PubMed Web of Science ®Google Scholar
• Nunez IP, Fantinelli J, Arbelaez LF, Mosca SM. Mitochondrial KATP channels participate in the limitation of infarct size by cariporide. Naunyn-Schmiedeberg's Arch Pharmacol. 2011;383:563–71.
   Google Scholar
• Baines CP, Wang L, Cohen MV, Downey JM. Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol. 1999;94:188–98.
   PubMed Web of Science ®Google Scholar
• Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113:1535–49.
   PubMed Web of Science ®Google Scholar
• Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol. 2011;50:940–50.
   PubMed Web of Science ®Google Scholar
• Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol. 2003;98:337–46.
   PubMed Web of Science ®Google Scholar
• Kozikowski AP, Sun H, Brognard J, Dennis PA. Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. J Am Chem Soc. 2003;125: 1144–5.
   PubMed Web of Science ®Google Scholar
• Stojanovic A, Marjanovic JA, Brovkovych VM, Peng X, Hay N, Skidgel RA, et al. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem. 2006;281:16333–9.
   PubMed Web of Science ®Google Scholar
• Sugden PH, Clerk A. Akt like a woman: gender differences in susceptibility to cardiovascular disease. Circ Res. 2001;88:975–7.
   PubMed Web of Science ®Google Scholar
• Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A. 2001;98:9666–70.
   PubMed Web of Science ®Google Scholar
• Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000;103:253–62.
   PubMed Web of Science ®Google Scholar
• Mullonkal CJ, Toledo-Pereyra LH. Akt in ischemia and reperfusion. J Invest Surg. 2007;20:195–203.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007;12:217–34.
   PubMed Web of Science ®Google Scholar
• Ji L, Zhang X, Liu W, Huang Q, Yang W, Fu F, et al. AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury. PloS One. 2013;8:e69910.
   PubMed Web of Science ®Google Scholar
• LaDisa JF, Jr., Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol. 2004;287:H601–7.
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Mickel M, Loffler M, Brandt U, Daut J. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542:735–41.
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Gopalan KV, Lareau RA, Srivastava DK, von Meltzer M, Daut J. Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J Physiol. 2003;547:387–93.
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Drose S, Brandt U, Lareau RA, Banerjee AL, Srivastava DK, et al. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. J Physiol. 2005;562:307–18.
   PubMed Web of Science ®Google Scholar
• Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74–85.
   PubMed Web of Science ®Google Scholar
• Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2 + overload. Am J Physiol Heart Circ Physiol. 2005;288:H1900–8.
   PubMed Web of Science ®Google Scholar
• Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 2007;81:1223–7.
   PubMed Web of Science ®Google Scholar
• Downey JM, Cohen MV. A really radical observation–a comment on Penna et al. in Basic Res Cardiol (2006) 101:180–189. Basic Res Cardiol. 2006;101:190–1.
   PubMed Web of Science ®Google Scholar
• Ji L, Fu F, Zhang L, Liu W, Cai X, Zheng Q, et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab. 2010;298:E871–80.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhu L, Zilbering A, Mahadev K, Motoshima H, Yao J, et al. Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases. Antioxid Redox Signal. 2005;7:526–37.
   PubMed Web of Science ®Google Scholar
• Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, et al. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 2004;24:1844–54.
   PubMed Web of Science ®Google Scholar
• Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res. 1989;65:607–22.
   PubMed Web of Science ®Google Scholar
• Horwitz LD, Fennessey PV, Shikes RH, Kong Y. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation. 1994; 89:1792–801.
   PubMed Web of Science ®Google Scholar
• Mitsos SE, Fantone JC, Gallagher KP, Walden KM, Simpson PJ, Abrams GD, et al. Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol. 1986;8:978–88.
   PubMed Web of Science ®Google Scholar
• Mitsos SE, Askew TE, Fantone JC, Kunkel SL, Abrams GD, Schork A, et al. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals. Circulation. 1986;73:1077–86.
   PubMed Web of Science ®Google Scholar
• Tanonaka K, Iwai T, Motegi K, Takeo S. Effects of N- (2-mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfused heart. Cardiovasc Res. 2003;57: 416–25.
   PubMed Web of Science ®Google Scholar
• de Oliveira UO, Bello-Kein A, de Oliveira AR, Kuchaski LC, Machado UF, Irigoyen MC, et al. Insulin alone or with captopril: effects on signaling pathways (AKT and AMPK) and oxidative balance after ischemia-reperfusion in isolated hearts. Fundam Clin Pharmacol. 2012;26:679–89.
   PubMed Web of Science ®Google Scholar
• Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001;52:181–98.
   PubMed Web of Science ®Google Scholar